background
evid
concern
efficaci
safeti
extracorpor
membran
oxygen
ecmo
patient
influenza
limit
case
report
studi
aim
investig
current
applic
efficaci
safeti
ecmo
sever
pneumoniaassoci
acut
respiratori
distress
syndrom
ard
chines
popul
method
multicentr
retrospect
cohort
studi
conduct
hospit
admit
patient
avian
influenza
viral
pneumonia
patient
admiss
provinc
china
octob
march
data
nation
health
famili
plan
commiss
china
includ
gener
condit
outcom
ecmo
manag
analys
success
wean
unsuccess
wean
group
compar
result
total
patient
age
year
analys
patient
male
mortal
patient
underw
invas
posit
pressur
ventil
ippv
rescu
ventil
strategi
implement
case
averag
ippv
durat
pao
fio
mmhg
tidal
volum
vt
ml
plateau
pressur
p
plat
cmh
preecmo
h
ecmo
pao
improv
mmhg
mmhg
paco
declin
mmhg
mmhg
haemorrhag
ventilatorassoci
pneumonia
vap
barotrauma
occur
patient
respect
compar
success
wean
patient
n
unsuccess
wean
patient
longer
durat
ippv
preecmo
vs
p
well
higher
p
plat
cmh
vs
cmh
p
vt
ml
vs
ml
p
h
ecmo
support
furthermor
unsuccess
wean
group
higher
mortal
vs
p
haemorrhag
vs
p
conclus
ecmo
effect
improv
oxygen
ventil
patient
avian
influenza
induc
sever
ard
earli
initi
ecmo
appropri
ippv
set
anticoagul
strategi
necessari
reduc
complic
keyword
extracorpor
membran
oxygen
ecmo
avian
influenza
acut
respiratori
distress
syndrom
ard
complic
mortal
background
avian
influenza
viral
pneumonia
manifest
vari
degre
dyspnea
associ
mortal
particular
patient
develop
rapidli
progress
pneumonia
progress
acut
respiratori
distress
syndrom
ard
mortal
sever
ard
high
time
effect
respiratori
support
particularli
import
treat
sever
ard
caus
avian
influenza
pneumonia
howev
sever
ard
induc
avian
influenza
pneumonia
might
manifest
refractori
hypoxaemia
even
appropri
invas
posit
pressur
ventil
ippv
support
extracorpor
membran
oxygen
ecmo
ultim
respiratori
support
method
directli
improv
oxygen
ventil
patient
well
enabl
implement
lung
protect
ventil
strategi
ecmo
breakthrough
treatment
sever
avian
influenza
outbreak
reduc
mortal
outbreak
therefor
believ
ecmo
could
also
effect
type
sever
viral
pneumonia
exist
studi
ecmo
treatment
avian
influenza
pneumonia
primarili
limit
case
report
studi
systemat
review
efficaci
safeti
ecmo
treat
diseas
therefor
particularli
import
understand
current
applic
ecmo
avian
influenza
pneumoniainduc
sever
ard
investig
applic
time
manag
strategi
ecmo
explor
possibl
reason
treatment
failur
base
current
studi
expect
standard
manag
ecmo
provid
descript
experi
use
ecmo
treat
patient
avian
influenza
pneumoniainduc
sever
ard
patient
laboratoryconfirm
avian
influenza
virusinduc
pneumonia
includ
studi
patient
admit
hospit
provinc
china
octob
march
report
nation
health
famili
plan
commiss
china
includ
patient
age
ys
support
ecmo
patient
lack
key
detail
record
paramet
ecmo
ventil
laboratori
find
exclud
includ
patient
divid
group
name
success
wean
group
unsuccess
wean
group
former
refer
group
patient
whose
condit
improv
wean
ecmo
least
h
unsuccess
wean
group
refer
die
voluntarili
discontinu
treatment
due
lack
improv
ecmo
support
gener
condit
includ
age
gender
pregnanc
statu
underli
diseas
time
onset
antivir
drug
administr
vasoact
drug
administr
preecmo
durat
ippv
preecmo
whether
rescu
ventil
strategi
includ
lung
recruit
maneuvr
proneposit
ventil
highfrequ
oscil
ventil
implement
preecmo
diseas
sever
score
total
durat
ecmo
ippv
collect
ecmo
blood
flow
h
ecmo
improv
circulatori
respiratori
physiolog
indic
consid
well
ippv
paramet
h
preecmo
h
ecmo
furthermor
anticoagul
indic
ecmo
includ
type
anticoagul
drug
method
use
maximum
minimum
valu
activ
coagul
time
act
activ
partial
thromboplastin
time
aptt
differ
maximum
minimum
act
aptt
h
ecmo
record
final
data
regard
complic
ecmo
therapi
includ
ecmo
ippvrel
complic
nosocomi
infect
collect
primari
outcom
inhospit
mortal
secondari
outcom
length
stay
intens
care
unit
icu
total
length
hospit
three
method
use
laboratori
diagnosi
name
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
viral
isol
serolog
test
avian
influenza
viru
use
modifi
haemagglutinin
inhibit
assay
defin
ard
accord
berlin
definit
pneumonia
diagnos
acut
ill
fever
cough
dyspneatachypnea
least
one
new
focal
chest
sign
support
find
lung
shadow
chest
radiograph
without
noninfecti
caus
primari
criteria
sever
pneumonia
follow
need
tracheal
intub
mechan
ventil
mv
need
vasoact
drug
activ
fluid
resuscit
due
septic
shock
secondari
criteria
follow
respiratori
rate
time
min
pao
fio
mmhg
multipl
lobe
infiltr
disturb
conscious
disorient
blood
urea
nitrogen
mmoll
systol
blood
pressur
mmhg
requir
activ
fluid
resuscit
patient
met
one
primari
criterion
least
three
secondari
criteria
diagnos
sever
pneumonia
criteria
diagnosi
vap
accord
european
centr
diseas
prevent
control
includ
follow
two
sequenti
chest
xray
ct
scan
suggest
imag
pneumonia
patient
underli
cardiac
pulmonari
diseas
one
definit
chest
xray
ct
scan
patient
without
underli
cardiac
pulmonari
diseas
fever
greater
leukocytosi
greater
equal
wbc
mm
leukopenia
less
equal
wbc
mm
least
one
follow
new
onset
purul
sputum
chang
characterist
sputum
b
cough
dyspnea
tachycardia
c
auscultatori
find
rale
bronchial
breath
sound
ronchi
wheez
worsen
ga
exchang
eg
oxygen
desatur
increas
oxygen
requir
increas
ventil
demand
includ
patient
first
describ
gener
condit
ecmo
model
paramet
ippv
paramet
chang
circul
respiratori
physiolog
indic
preecmo
ecmo
statu
anticoagul
ecmo
complic
ecmo
therapi
includ
patient
compar
patient
success
unsuccess
wean
ecmo
regard
item
analys
perform
use
spss
softwar
normal
distribut
continu
variabl
express
mean
sd
compar
use
ttest
chisquar
test
nonnorm
distribut
continu
variabl
express
median
quartil
compar
use
wilcoxon
ranksum
test
categor
variabl
compar
use
x
test
pvalu
consid
signific
total
patient
diagnos
avian
influenza
virusrel
pneumonia
patient
admit
hospit
provinc
china
octob
march
report
nation
health
famili
plan
commiss
china
medic
record
patient
avail
patient
report
support
ecmo
one
patient
lack
ippv
ecmo
paramet
preecmo
ecmo
elimin
particip
therefor
patient
ultim
select
fig
data
patient
male
averag
age
year
analys
patient
age
total
patient
underli
diseas
patient
treat
steroid
immunosuppress
agent
within
month
admiss
hospit
patient
pregnant
sequenti
organ
failur
assess
sofa
score
point
murray
score
point
time
onset
antivir
drug
administr
approxim
time
onset
ecmo
support
approxim
highdos
vasoact
drug
need
maintain
blood
pressur
patient
durat
ippv
preecmo
approxim
rescu
ventil
strategi
includ
recruit
manoeuvr
rm
proneposit
ventil
pp
high
frequenc
oscillatori
ventil
hfov
need
patient
preecmo
total
durat
ippv
ecmo
approxim
respect
patient
success
wean
ecmo
patient
die
due
uncontrol
haemorrhag
patient
septic
shock
patient
due
progress
lung
infect
patient
due
bloodstream
infect
heart
failur
patient
discontinu
treatment
improv
patient
one
patient
show
aggreg
lung
infect
wean
eventu
die
due
septic
shock
inhospit
mortal
length
icu
stay
total
length
hospit
tabl
patient
treat
use
venoven
ecmo
vv
ecmo
model
total
patient
sever
cardiac
insuffici
cardiogen
shock
treat
use
venousarteri
ecmo
va
ecmo
model
ecmo
equip
mainli
provid
maquet
shanghai
medic
equip
co
ltd
sorin
shanghai
medic
equip
co
ltd
pump
sorin
stockert
centrifug
pump
system
scpscpc
oxygen
eo
ecmo
pump
maquet
rotaflow
oxygen
quadrox
pl
chang
ippv
paramet
physiolog
indic
patient
ecmo
ventil
paramet
includ
fio
posit
endexpiratori
pressur
peep
p
plat
vt
significantli
decreas
patient
ecmo
vital
sign
includ
heart
rate
respiratori
rate
spo
arteri
blood
ga
analysi
abg
includ
ph
paco
pao
level
improv
patient
ecmo
support
tabl
monitor
anticoagul
patient
receiv
continu
infus
unfraction
heparin
anticoagul
howev
heparin
discontinu
patient
cerebr
haemorrhag
activ
gastrointestin
haemorrhag
act
h
h
h
ecmo
aptt
h
ecmo
respect
complic
ecmo
therapi
studi
rate
gastrointestin
haemorrhag
cerebr
haemorrhag
brain
death
renal
insuffici
dissemin
intravascular
coagul
dic
hyperglycaemia
ecmo
oxygen
thrombosi
higher
compar
relev
data
ecl
registri
report
new
case
vap
develop
patient
ecmo
incid
rate
new
case
barotrauma
occur
patient
account
case
addit
patient
urinari
infect
incid
rate
patient
catheterrel
blood
stream
infect
crbsi
incid
rate
tabl
comparison
patient
success
unsuccess
wean
ecmo
group
contain
patient
success
wean
ecmo
group
includ
patient
unsuccess
wean
ecmo
compar
patient
success
wean
ecmo
unsuccess
wean
group
higher
mortal
vs
respect
p
older
year
vs
year
respect
p
like
diabet
mellitu
vs
respect
p
frequent
sever
condit
sofa
point
vs
point
respect
p
preecmo
meanwhil
longer
durat
ippv
vs
respect
p
lower
pao
fio
level
mmhg
vs
mmhg
respect
p
higher
rate
rescu
ventil
strategi
vs
respect
p
ecmo
support
signific
differ
found
total
durat
ippv
total
durat
ecmo
length
icu
stay
length
hospit
two
group
tabl
ecmo
blood
flow
significantli
differ
two
group
initi
ecmo
support
howev
success
wean
group
vs
unsuccess
wean
group
signific
decreas
blood
flow
correl
increas
durat
support
lmin
vs
lmin
respect
p
h
ecmo
l
min
vs
lmin
respect
p
h
ecmo
addit
file
success
wean
group
compar
unsuccess
wean
group
fio
vs
fig
addit
file
vital
sign
improv
significantli
differ
two
group
preecmo
ecmo
support
addit
file
patient
unsuccess
wean
ecmo
compar
patient
success
wean
ecmo
sever
acidosi
ph
vs
respect
p
higher
paco
mmhg
vs
mmhg
respect
p
higher
lactat
concentr
mmoll
vs
mmoll
p
preecmo
ph
paco
differ
significantli
two
group
ecmo
support
patient
eventu
success
wean
ecmo
gradual
ascend
tendenc
pao
h
ecmo
sustain
low
level
lactat
fig
addit
file
earli
stage
ecmo
h
success
wean
group
show
smaller
differ
act
max
act
min
unsuccess
wean
group
vs
h
p
vs
h
p
howev
trend
found
regard
differ
maximum
minimum
aptt
differ
two
group
mechan
complic
associ
ecmo
vap
barotrauma
success
wean
group
compar
unsuccess
wean
group
lower
haemorrhag
rate
vs
respect
p
lower
rate
renal
insuffici
vs
respect
p
lower
rate
liver
failur
vs
respect
p
lower
heart
failur
rate
vs
respect
p
studi
first
systemat
comprehens
discuss
well
elabor
current
applic
efficaci
safeti
ecmo
patient
pneumoniarel
ard
studi
shown
mortal
ard
reduc
follow
ecmo
treatment
present
studi
larg
sampl
investig
mortal
ard
inhospit
mortal
high
studi
late
initi
ecmo
inappropri
ippv
set
ecmo
ecmo
complic
might
explain
rel
high
mortal
moreov
multicentr
collabor
studi
experi
ecmo
vari
among
centr
addit
file
might
anoth
reason
high
mortal
accord
extracorpor
life
support
organ
elso
data
ecmo
indic
death
risk
exce
ie
pao
fio
mmhg
fio
murray
score
patient
met
indic
ecmo
support
durat
mv
day
preecmo
import
prognost
factor
death
patient
success
wean
group
durat
ippv
preecmo
howev
durat
even
longer
among
patient
unsuccess
wean
group
moreov
rescu
ventil
strategi
implement
patient
ecmo
partial
delay
time
ecmo
comparison
ecmo
initi
h
h
ippv
among
patient
australia
new
zealand
significantli
shorter
case
therefor
emphas
earli
implement
ecmo
patient
principl
ippv
ecmo
lung
rest
strategi
reva
registri
studi
examin
patient
ard
show
high
p
plat
cmh
day
ecmo
relat
high
mortal
studi
preecmo
p
plat
level
high
cmh
high
p
plat
lead
overdistens
alveoli
caus
lung
volutrauma
shear
forc
overdistend
collaps
alveoli
aggreg
vili
ultim
increas
mortal
although
p
plat
valu
show
high
peep
level
within
ecmo
relat
decreas
mortal
although
differ
observ
peep
level
two
group
specul
downregul
peep
ecmo
might
aggrav
occurr
collapseinduc
injuri
led
atelectasi
sputum
discharg
obstacl
therefor
ippv
paramet
includ
high
p
plat
vt
level
low
peep
set
might
unreason
studi
lung
rest
mainten
open
alveoli
achiev
incid
ecmo
oxygen
thrombu
haemorrhag
organ
failur
studi
high
suggest
problem
exist
anticoagul
manag
organ
support
treatment
ecmo
found
unsuccess
wean
group
larger
fluctuat
act
differ
act
max
act
min
larger
earli
stage
anticoagul
effect
might
suggest
rel
unstabl
anticoagul
higher
risk
haemorrhag
moreov
incid
rate
vap
ecmo
high
partial
attribut
long
cours
pneumonia
prolong
durat
ippv
therefor
intensif
airway
manag
extrem
necessari
studi
limit
natur
studi
requir
collect
data
multipl
consecut
time
point
evalu
efficaci
ecmo
retrospect
studi
miss
data
unabl
success
collect
data
h
preecmo
h
postecmo
addit
number
subject
small
perform
multipl
regress
analysi
explor
risk
factor
unsuccess
wean
ecmo
ecmo
effect
improv
oxygen
ventil
patient
avian
influenza
induc
sever
ard
earli
initi
ecmo
appropri
ippv
set
anticoagul
strategi
necessari
reduc
complic
fig
comparison
ippv
paramet
abg
two
group
patient
ecmo
success
wean
group
compar
unsuccess
wean
group
fio
vs
respect
h
p
vs
respect
h
p
monitor
p
plat
cmh
vs
cmh
respect
h
p
cmh
vs
cmh
respect
h
p
monitor
vt
ml
vs
ml
respect
h
p
ml
vs
ml
respect
h
p
ecmo
support
howev
differ
peep
ecmo
two
group
patient
unsuccess
wean
group
compar
patient
success
wean
group
sever
acidosi
ph
vs
respect
p
higher
paco
mmhg
vs
mmhg
respect
p
higher
lactat
concentr
mmoll
vs
mmoll
respect
p
preecmo
ph
paco
significantli
differ
two
group
ecmo
therapi
patient
eventu
wean
success
ecmo
gradual
ascend
tendenc
pao
h
ecmo
sustain
low
level
lactat
ecmo
therapi
